Cardiff Oncology, Inc.
CRDFNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $63.47M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.76$3.31
- Volume (live)
- -
- Avg. volume (3M)
- 682.00K
Cardiff Oncology (CRDF) Stock Price & Financial Analysis
Cardiff Oncology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.91 - $0.97 |
|---|---|
| 52-Week High | $3.31 |
| 52-Week Low | $0.76 |
| Open | $0.93 |
| Volume (last close) | 228.68K |
| Average Volume (3M) | 682.00K |
| Revenue (TTM) | 508.00K |
|---|---|
| Net Income (TTM) | -40.05M |
| Free Cash Flow (TTM) | -40.92M |
| EPS (TTM) | −$0.59 |
| Profit Margin | -7884.06% |
| Operating Margin | -8320.08% |
| Return on Equity (ROE) | -150.95% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 63.47M |
|---|---|
| Shares Outstanding | 68.40M |
| Price to Sales (P/S) | 124.95 |
| Price to Book (P/B) | 2.39 |
| EV/EBITDA | -1.39 |
| 50-Day MA | $1.09 |
|---|---|
| 200-Day MA | $1.52 |
| 1-Year Change | −58.01% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Cardiff Oncology at a Glance
As of the Oct 22, 2026 close, Cardiff Oncology (CRDF) has a market capitalization of $63.47M. The stock trades at 125.0× sales. Over the trailing twelve months it lost $40.05M on revenue of $508.00K and burned $40.92M of free cash flow. Revenue fell 7.0% year over year.
As of its latest reported balance sheet, it holds $9.20M in cash and securities against $457.00K of debt, a net cash position of $8.74M.
Cardiff Oncology does not currently pay a dividend.
The share price is down 58.0% over the past year. At $0.93 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.76 to $3.31, below its 200-day moving average of $1.52.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $7.50, 708.2% above the Oct 22, 2026 close.
Frequently Asked Questions About Cardiff Oncology
What is the current stock price for CRDF?
As of the Oct 22, 2026 close, CRDF stock trades at $0.93. The 52-week range is $0.76–$3.31, with a day range of $0.91–$0.97.
What is the P/E ratio for CRDF?
The P/E ratio (Price-to-Earnings) for CRDF is shown in the Key Statistics section. This valuation metric helps compare Cardiff Oncology, Inc. to industry peers.
Does CRDF pay dividends?
Cardiff Oncology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRDF?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for CRDF is Hold. The average 12-month price target is $7.50, a 708.2% upside from the Oct 22, 2026 close of $0.93.
What is the market cap of CRDF?
As of the Oct 22, 2026 close, Cardiff Oncology's market capitalization is $63.5M, classifying it as a micro-cap company. Cardiff Oncology operates in the Healthcare sector within the Biotechnology industry.